RxDoctor Payments Data

David Friedmann, MD

Otology & Neurotology · New York, NYNPI 1063656296

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Cochlear Americas accounts for 75.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $2,897 and has fallen 93.8% since, to $180 in 2025.

$10,790in general payments, 2019–2025

Across 69 payments — averaging $156.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cochlear Americas$8K
  • Med-el Corporation$1K
  • Vertex$458
  • Iotamotion, Inc.$421
  • Nobelpharma America, LLC$216
  • Advanced Bionics, LLC$196
  • plus $227 from 3 others
$202,202in research payments, 2019–2025

Across 8 payments — averaging $25,275 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Nobelpharma America, LLC$165K
  • Cochlear Americas$37K

What the payments were for

  • Consulting fees$4,17539%
  • Travel & lodging$3,62034%
  • Food & beverage$2,99528%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,790 in reported general payments places this provider in the 80th percentile of 26 otology & neurotology providers in New York.

See all otology & neurotology providers in New York

Medicare billing

Part B allowed, 2024
$61,347
Medicare patients
212
Services billed
446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth14$1,205

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →